Ad
related to: bystolic side effects in women
Search results
Results From The WOW.Com Content Network
Several studies have suggested that nebivolol has reduced typical beta-blocker-related side effects, such as fatigue, clinical depression, bradycardia, or impotence. [35] [36] [37] However, according to the FDA [38] Bystolic is associated with a number of serious risks.
Common side effects include headache, feeling tired, diarrhea, and swelling in the legs. [7] More severe side effects include worsening asthma, blocking the ability to recognize low blood sugar, and worsening heart failure. [9] There are concerns that use during pregnancy may be harmful to the baby. [10]
Common side effects include low blood pressure with standing, dizziness, feeling tired, and nausea. [4] Serious side effects may include low blood pressure, liver problems, heart failure, and bronchospasm. [4] Use appears safe in the latter part of pregnancy and it is not expected to cause problems during breastfeeding.
Constipation and an upset stomach are among the most common side effects associated with oral iron supplements, Cunningham says. ... “women who are in their reproductive years should be eating ...
New research has found that about 2.2 million new diagnoses of type 2 diabetes and 1.2 million new cases of cardiovascular disease were attributed to sugar-sweetened sodas and juices each year.
Common adverse effects of bupropion with the greatest difference from placebo are dry mouth, nausea, constipation, insomnia, anxiety, tremor, and excessive sweating. [10] [11] Raised blood pressure is notable. [23] Rare but serious side effects include seizures, [10] [11] liver toxicity, [24] psychosis, [25] and risk of overdose. [26]
Pregnant women are advised to limit their caffeine to 200 mg per day. juanma hache / Moment - Getty Images ... However, she offers advice on minimizing the negative side effects of coffee: "Choose ...
COX-2 selective inhibitors have fewer gastrointestinal side effects, but promote thrombosis, and some of these agents substantially increase the risk of heart attack. As a result, certain COX-2 selective inhibitors—such as rofecoxib —are no longer used due to the high risk of undiagnosed vascular disease . [ 11 ]